Home › Schizophrenia › California › Chino
Schizophrenia clinical trials in Chino, CA
6 studies for Schizophrenia are looking for participants at sites in and around Chino (within about 30 miles). Open a study to see who can join and how to contact the study team.
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
RecruitingPhase 3
- Local Institution - 0188, Chino
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RecruitingPhase 3
- Neurocrine Clinical Site, Chino
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RecruitingPhase 3
- Inland Psychiatric Medical Group., Chino
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
- Neurocrine Clinical Site, Chino
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
RecruitingPhase 3
- Inland Psychiatric Medical Group., Chino
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
RecruitingObservational study
- Inland Psychiatric Medical Group (IPMG)-Chino, Chino
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL20 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Hialeah, FL13 studies
- San Diego, CA13 studies
- New York City, NY13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in Chino
- Major Depressive Disorder6 studies
- Depression4 studies
- Alzheimer's Disease3 studies
- Psychotic Disorders3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.